Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

882730

registered interest
date	13/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of the Early Access to Medicines Scheme in encouraging pharmaceutical companies to launch promising and innovative medicines in the UK.
tabling member constituency	Penistone and Stocksbridge
tabling member printed	Angela Smith
uin	135792
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>The Life Sciences Industrial Strategy set out our vision of being a world-leader in developing and bringing to market innovative medicines to improve life-chances of United Kingdom patients. It highlighted the importance of evolving and simplifying the access system for new medicines by implementing, and building on, the findings of the Accelerated Access Review.</p><p> </p><p>The Early Access to Medicines Scheme (EAMS) is an essential part of delivering on this ambition. It has been effective in encouraging companies to bring their products to the UK and market them. The figures below show increasing engagement from industry as the scheme has progressed.</p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>2014/15</p></td><td><p>2015/16</p></td><td><p>2016/17</p></td><td><p>2017/18</p></td></tr><tr><td><p>Number of Promising Innovative Medicines awarded</p></td><td><p>8</p></td><td><p>6</p></td><td><p>17</p></td><td><p>20</p></td></tr><tr><td><p>Number of Scientific Opinions awarded</p></td><td><p>1</p></td><td><p>8</p></td><td><p>3</p></td><td><p>7</p></td></tr></tbody></table><p> </p><p>The EAMS task group has been established to provide a forum for industry to engage with the Government, the devolved administrations and arm’s length bodies, driving further improvements to the scheme and making the UK a more attractive place to test and deliver new pharmaceuticals.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/04/2018 15:40:30 answering member 4067 label Biography information for Steve Brine
tabling member	1564 label Biography information for Angela Smith

882729

registered interest
date	13/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effectiveness of the Early Access to Medicines Scheme in ensuring that patients have access to promising and innovative medicines as early as possible.
tabling member constituency	Penistone and Stocksbridge
tabling member printed	Angela Smith
uin	135791
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>Since the Early Access to Medicines Scheme (EAMS) was launched in 2014, the Medicines and Healthcare products Regulatory Agency has awarded 50 promising innovative medicines designations and 21 positive scientific opinions as part of the scheme. NHS England records show that 1,100 patients in England have accessed treatment through EAMS.</p><p> </p><p>Since the publication of the independent review of the EAMS the Government has made a number of improvements. Partners have worked together to provide updated guidance on the benefits and entry requirements for EAMS and are developing further guidance on collecting real world data in the National Health Service to further inform value assessment in a National Institute for Health and Care Excellence appraisal.</p><p> </p><p>We have also established the EAMS task group to provide a forum for industry to engage and make suggestions to the Government, the devolved administrations and arm’s length bodies regarding EAMS as per the recommendations of the 2016 review.</p><p> </p><p>We are also applying the learning from EAMs to the development of the Accelerated Access Pathway. Due to launch shortly, this will be a streamlined route to market which will help get the most innovative treatments to patients faster.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/04/2018 15:38:08 answering member 4067 label Biography information for Steve Brine
tabling member	1564 label Biography information for Angela Smith

882727

registered interest
date	13/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dermatitis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of adults with atopic dermatitis in (a) Penistone and Stocksbridge constituency, (b) England and (c) the UK.
tabling member constituency	Penistone and Stocksbridge
tabling member printed	Angela Smith
uin	135789
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>This data is not available, however, the National Institute for Health and Care Excellence estimates that atopic dermatitis (atopic eczema) is a common skin condition that affects between 2–10% of adults.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/04/2018 16:18:03 answering member 4067 label Biography information for Steve Brine
tabling member	1564 label Biography information for Angela Smith

882728

registered interest
date	13/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Skin Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure patients in England with (a) skin conditions and (b) atopic dermatitis are able to access to new innovative treatments.
tabling member constituency	Penistone and Stocksbridge
tabling member printed	Angela Smith
uin	135790
answer	answer is ministerial correction date of answer 23/04/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body that provides guidance on the prevention and treatment of ill health and the promotion of good health and social care. NICE has published a range of guidance products for the management of skin conditions, including technology appraisals, guidelines and quality standards, which can be accessed at the following link:</p><p> </p><p><a href="https://www.nice.org.uk/guidance/conditions-and-diseases/skin-conditions/skin-conditions--general-and-other#technology-appraisal-guidance" target="_blank">https://www.nice.org.uk/guidance/conditions-and-diseases/skin-conditions/skin-conditions--general-and-other#technology-appraisal-guidance</a></p><p> </p><p>National Health Service commissioners are legally required to fund treatments recommended by NICE in its technology appraisal guidance.</p><p> </p><p>The Government takes the issue of ensuring rapid access to innovative therapies very seriously, which is why on 3 November 2017, we published our response to the Accelerated Access Review. We set out plans to give patients quicker access to life-changing treatments and make the United Kingdom the best place in the world for industry to invest and innovate.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/04/2018 15:39:05 answering member 4067 label Biography information for Steve Brine
tabling member	1564 label Biography information for Angela Smith

794023

registered interest
date	22/11/2017
answering body	Department for Education
answering dept id	60
answering dept short name	Education
answering dept sort name	Education
hansard heading	Pupils: Health
house id	1
legislature	25259 pref label House of Commons
question text	To To ask the Secretary of State for Education, pursuant to the Answer of 9 November 2017 to Question 110875, when her Department last reviewed the statutory guidance entitled Supporting pupils with medical conditions at school; and whether any changes have been made to that guidance to address a lack of awareness and compliance in schools.
tabling member constituency	Penistone and Stocksbridge
tabling member printed	Angela Smith
uin	115111
answer	answer is ministerial correction date of answer 30/11/2017 answer text <p>The department worked with a range of stakeholders including the Health Conditions in Schools Alliance, unions, members of the school workforce and parents and their children on developing the statutory guidance, a draft of which was subject to public consultation in early 2014. Updates to the guidance were made in December 2015, which included clarifying the distinction between statutory and non-statutory guidance and adding references to the special educational needs and disabilities code of practice.</p><p> </p><p>Governing boards should ensure that all schools develop a policy for supporting pupils with medical conditions, which is reviewed regularly and is readily accessible to parents and school staff. We keep the guidance under review, including in the context of school awareness, and the role it plays in securing accessibility of school policies.</p><p> </p><p>Ofsted’s Common Inspection Framework requires inspectors, in making judgements upon schools, to pay particular attention to the outcomes of a range of groups of pupils, including those with medical needs. Ofsted included guidance to inspectors on this matter in their March 2017 school inspection update, reminding inspectors that they should consider how schools are meeting the needs of pupils with medical conditions.</p> answering member constituency Scarborough and Whitby answering member printed Mr Robert Goodwill grouped question UIN 115112 115113 question first answered 30/11/2017 15:25:20 answering member 1562 label Biography information for Sir Robert Goodwill
tabling member	1564 label Biography information for Angela Smith

782107

registered interest
date	01/11/2017
answering body	Department for Education
answering dept id	60
answering dept short name	Education
answering dept sort name	Education
hansard heading	Pupils: Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Education, if she will amend the statutory guidance entitled Supporting pupils with medical conditions at school to include a requirement for all schools to publish their medical conditions policies.
tabling member constituency	Penistone and Stocksbridge
tabling member printed	Angela Smith
uin	110875
answer	answer is ministerial correction date of answer 09/11/2017 answer text <p>We know how important it is that children with medical conditions are supported to enjoy a full education. That is why we introduced the duty, under section 100 of the Children and Families Act 2014, to require governing bodies to make arrangements to support pupils with medical conditions and have provided statutory guidance outlining schools’ responsibilities in this area.</p><p> </p><p>We keep this statutory guidance under review. We will continue to ensure that it clearly sets out the arrangements that governing boards should be making to support pupils with medical conditions, based on best practice.</p><p> </p><p>All governing boards should ensure that the school's policy for supporting pupils with medical conditions is reviewed regularly and is readily accessible to parents and school staff.</p> answering member constituency Scarborough and Whitby answering member printed Mr Robert Goodwill question first answered 09/11/2017 14:56:25 answering member 1562 label Biography information for Sir Robert Goodwill
tabling member	1564 label Biography information for Angela Smith

794024

registered interest
date	22/11/2017
answering body	Department for Education
answering dept id	60
answering dept short name	Education
answering dept sort name	Education
hansard heading	Pupils: Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Education, pursuant to the Answer of 9 November 2017 to Question 110875, when her Department plans to review the statutory guidance entitled Supporting pupils with medical conditions at school; and if her Department will amend that guidance to include a requirement for governing bodies to ensure that all schools publish their policy for supporting pupils with medical conditions on the school’s website so that it is readily accessible to parents and school staff.
tabling member constituency	Penistone and Stocksbridge
tabling member printed	Angela Smith
uin	115112
answer	answer is ministerial correction date of answer 30/11/2017 answer text <p>The department worked with a range of stakeholders including the Health Conditions in Schools Alliance, unions, members of the school workforce and parents and their children on developing the statutory guidance, a draft of which was subject to public consultation in early 2014. Updates to the guidance were made in December 2015, which included clarifying the distinction between statutory and non-statutory guidance and adding references to the special educational needs and disabilities code of practice.</p><p> </p><p>Governing boards should ensure that all schools develop a policy for supporting pupils with medical conditions, which is reviewed regularly and is readily accessible to parents and school staff. We keep the guidance under review, including in the context of school awareness, and the role it plays in securing accessibility of school policies.</p><p> </p><p>Ofsted’s Common Inspection Framework requires inspectors, in making judgements upon schools, to pay particular attention to the outcomes of a range of groups of pupils, including those with medical needs. Ofsted included guidance to inspectors on this matter in their March 2017 school inspection update, reminding inspectors that they should consider how schools are meeting the needs of pupils with medical conditions.</p> answering member constituency Scarborough and Whitby answering member printed Mr Robert Goodwill grouped question UIN 115111 115113 question first answered 30/11/2017 15:25:20 answering member 1562 label Biography information for Sir Robert Goodwill
tabling member	1564 label Biography information for Angela Smith

794025

registered interest
date	22/11/2017
answering body	Department for Education
answering dept id	60
answering dept short name	Education
answering dept sort name	Education
hansard heading	Pupils: Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Education, pursuant to the Answer of 9 November to Question 110875, how her Department (a) monitors that governing boards are ensuring that the school’s policy for supporting pupils with medical conditions is reviewed regularly and is readily accessible to parents and school staff and (b) responds to governing boards and schools when there is evidence of non-compliance to their statutory obligations.
tabling member constituency	Penistone and Stocksbridge
tabling member printed	Angela Smith
uin	115113
answer	answer is ministerial correction date of answer 30/11/2017 answer text <p>The department worked with a range of stakeholders including the Health Conditions in Schools Alliance, unions, members of the school workforce and parents and their children on developing the statutory guidance, a draft of which was subject to public consultation in early 2014. Updates to the guidance were made in December 2015, which included clarifying the distinction between statutory and non-statutory guidance and adding references to the special educational needs and disabilities code of practice.</p><p> </p><p>Governing boards should ensure that all schools develop a policy for supporting pupils with medical conditions, which is reviewed regularly and is readily accessible to parents and school staff. We keep the guidance under review, including in the context of school awareness, and the role it plays in securing accessibility of school policies.</p><p> </p><p>Ofsted’s Common Inspection Framework requires inspectors, in making judgements upon schools, to pay particular attention to the outcomes of a range of groups of pupils, including those with medical needs. Ofsted included guidance to inspectors on this matter in their March 2017 school inspection update, reminding inspectors that they should consider how schools are meeting the needs of pupils with medical conditions.</p> answering member constituency Scarborough and Whitby answering member printed Mr Robert Goodwill grouped question UIN 115111 115112 question first answered 30/11/2017 15:25:20 answering member 1562 label Biography information for Sir Robert Goodwill
tabling member	1564 label Biography information for Angela Smith

1128964

registered interest
date	03/06/2019
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Livestock: Animal Welfare
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Environment, Food and Rural Affairs, if he will (a) take steps through the Agriculture Bill to increase animal health standards and (b) make an assessment of the merits of a resilient approach to disease management to reduce productivity losses and subsequent food shortages.
tabling member constituency	Penistone and Stocksbridge
tabling member printed	Angela Smith
uin	259124
answer	answer is ministerial correction date of answer 11/06/2019 answer text <p>The Government is highly supportive of a resilient and preventative approach to livestock disease which supports higher productivity in farming and enables wider benefits. The approach was endorsed in responses to our consultation paper <em>Health and Harmony: the future for food, farming and the environment in a Green Brexit</em>. The potential was set out, for example, in ‘<em>Study to Model the Impact of Controlling Endemic Cattle Diseases and Conditions on National Cattle Productivity, Agricultural Performance and Greenhouse Gas Emissions’</em>.</p><p><em> </em></p><p>We are now working with industry and veterinary representatives to develop practical plans to further this approach and the Agriculture Bill is drafted to give the Secretary of State powers to make payments to protect and improve the health of livestock and to collect and share data relating to livestock health and traceability.</p> answering member constituency Scarborough and Whitby answering member printed Mr Robert Goodwill grouped question UIN 259123 question first answered 11/06/2019 09:26:11 answering member 1562 label Biography information for Sir Robert Goodwill
tabling member	1564 label Biography information for Angela Smith

1110883

registered interest
date	09/04/2019
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Fisheries
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Environment, Food and Rural Affairs, what assessment he has made of the Environment Agency ability to carry out all its statutory duties in relation to fisheries; and if he will make a statement.
tabling member constituency	Penistone and Stocksbridge
tabling member printed	Angela Smith
uin	242777
answer	answer is ministerial correction date of answer 16/04/2019 answer text <p>The EA continues to fulfil its statutory duties in relation to fisheries.</p><p> </p><p>Freshwater fisheries regulation is a core role and unique activity that only the EA can fulfil. The EA makes resources available to deliver current regulations, including the rod and net licensing system; scheduled reviews of Net Limitation Orders; reviewing and consolidating fishery byelaws; making new byelaws where this is necessary to protect stocks; and determining fishery management permit applications.</p> answering member constituency Scarborough and Whitby answering member printed Mr Robert Goodwill question first answered 16/04/2019 11:18:45 answering member 1562 label Biography information for Sir Robert Goodwill
tabling member	1564 label Biography information for Angela Smith